Clinicopathological factor | OR | 95% CI | p-value |
---|---|---|---|
Presence of ESD history | 3.77 | 1.56–9.08 | 0.0031 |
Presence of CRT history | 4.19 | 1.26–13.96 | 0.0196 |
Ce-Ut of location | 1.19 | 0.43–3.28 | 0.874 |
0-Is/0-IIa | 1.39 | 0.40–4.80 | 0.598 |
Tumor size (≤ 40, > 40 mm) | 2.71 | 1.18–6.19 | 0.0180 |
Presence of muscle injury | 0.52 | 0.11–2.45 | 0.415 |
Entire circumferential resection | 5.51 | 2.38–12.78 |  < 0.0001 |
pT1b | 0.82 | 0.21–3.15 | 0.778 |
Presence of additional CRT after ESD | 0.57 | 0.16–2.00 | 0.383 |
TrA injection + oral PSL use | 1.80 | 0.84–3.84 | 0.126 |